Sekulic, Aleksandar <br/><br/>
Efficacy and safety of vismodegib in advanced basal-cell carcinoma.  [electronic resource] 

 -  The New England journal of medicine  Jun 2012 
 - 2171-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa1113713  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anilides--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Carcinoma, Basal Cell--drug therapy<br/>Female<br/>Hedgehog Proteins--antagonists & inhibitors<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Pyridines--adverse effects<br/>Signal Transduction--drug effects<br/>Skin Neoplasms--drug therapy<br/>Treatment Outcome